Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - pradip+bajgain
1
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Fully Human Chimeric Antigen Receptors Against CD276 for the Treatment of Solid Tumors
Summary: The National Cancer Institute (NCI) seeks research co-development partners and licensees for a panel of five fully human antibodies against CD276 for the treatment of solid tumors. The collection also includes human CARs incorporating the antibodies for immunotherapeutic use. Description of Technology: Chimeric antigen receptor (CAR)-T...
Published: 12/20/2024
|
Inventor(s):
Brad St. Croix
,
Pradip Bajgain
,
Yang Feng
Keywords(s):
Category(s):
Application > Therapeutics
,
Collaboration Sought > Collaboration
,
TherapeuticArea > Oncology
,
TherapeuticArea > Immunology
,
Collaboration Sought > Licensing